Hosted on MSN13h
Johnson & Johnson’s TREMFYA® Shows Promising Results in Ulcerative Colitis Patients
Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...
Medscape13h
Management of Acute Severe Ulcerative Colitis
Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...
BlackDoctor21h
Eating with Ulcerative Colitis: A Black Nutritionist’s Guide to Safe & Delicious Foods
Living with ulcerative colitis doesn’t mean giving up the flavors you love. You can enjoy delicious meals without painful ...